Forms of Vaccine Support Designs
Vaccine support is a very fragile unit in medication as it involves the study of illness characteristics and how to come up with a cure of the disease. Good vaccines should not affect the way other cells behave but rather only fight the relevant microbes that cause an illness. Vaccines that happen to affect various cells or alter their functionality when the immune system is responding to microbe is termed to have negative effects thus it cannot carry its purpose effectively. For a support vaccine to be termed as suitable it should poses some level of compatibility with other medications that can be related to similar ailments and also at what part of the world is the medicine recommended for use are some of the issues that should be factored in when designing good vaccine support medication.
The main type of support vaccines are five and will be discussed in the article and they are: toxic vaccine, inactive vaccine, attenuate vaccine, subunit vaccine and conjugate vaccine. Live, attenuated vaccine is a type of vaccine that is developed in the laboratory where the real microbe is weakened to a level that is not harmful to the body. This is done for the purpose of studying how the real microbe behaves in the natural infection. The long run aim is to rate the amount of antibodies that the body can possibly release to fight the microbe and how to design a drug that can fight the disease with a few doses. A number of examples diseases are yellow fever, smallpox, measles, mumps, rubella, chickenpox and rotavirus.
Harmful chemicals are produced by bacteria that is toxic to the body cells. The toxic produced by the bacteria becomes harmful to the body. Formaldehyde and sterilized water creates solution of formalin which can be used to treat inactive toxins. After the body is immunized it learns how to fight the natural toxic substance by releasing antibodies that fight the toxic substance and finally stop its production. Diphtheria and tetanus are some of the common produced toxic substance by the body.
Thirdly, when designing a conjugate vaccine the scientists link toxoids or antigens from a microbe to the immune system to recognize it to the polysaccharides where this linkage helps immature immune system like that of an infant to react to polysaccharide coating and defend that body against diseases caused by bacterium. When there are sugar coating on a bacterium that ensures that bacterium antigens protect the immune system of newborn does not react to bacterium antibodies is known as polysaccharides.